Fisher to sell diaDexus' PLAC in US:
This article was originally published in Clinica
Executive Summary
Diagnostics firm diaDexus is set to make its automated PLAC blood test available in the US through Fisher HealthCare. Fisher will sell the test, which was cleared for use with Hitachi, Hitachi Roche P-Modular and Olympus chemistry analysers by the FDA in February 2008 (see Clinica No 1296, p 26), to US hospital clinical laboratories. According to South San Francisco, California-based diaDexus, the product is the only FDA-cleared blood test to asses risk for both coronary heart disease and ischemic stroke associated with atherosclerosis. Financial details of the deal were not disclosed.